About the Authors
- Shervin Assassi
-
Contributed equally to this work with: Shervin Assassi, Astrud L. Leyva
* E-mail: shervin.assassi@uth.tmc.edu
Affiliation Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Astrud L. Leyva
-
Contributed equally to this work with: Shervin Assassi, Astrud L. Leyva
Affiliation Department of Medicine, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America
- Maureen D. Mayes
-
Affiliation Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Roozbeh Sharif
-
Affiliations Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America, Department of Medicine, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America
- Deepthi K. Nair
-
Affiliation Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Michael Fischbach
-
Affiliation Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America
- Ngan Nguyen
-
Affiliation Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- John D. Reveille
-
Affiliation Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
- Emilio B. Gonzalez
-
Affiliation Department of Medicine, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America
- Terry A. McNearney
-
Current address: Eli Lilly and Company, Indianapolis, Indiana, United States of America
Affiliation Department of Medicine, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America
- for the GENISOS Study Group
Competing Interests
The authors wish to declare the following competing interest: Dr. Terry A. McNearney is an employee of Eli Lilly and Company. There are no patents, products, in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. Dr. McNearney was the former principal investigator of GENISOS study at University of Texas Medical Branch at Galveston. Eli Lilly and Company did not have any role in study design, data collection, analysis of the data, and writing the manuscript. Other authors have nothing to declare.
Author Contributions
Conceived and designed the experiments: SA ALL MDM RS JDR EBG TAM. Performed the experiments: SA ALL MDM RS DKN MF NN JDR EBG TAM. Analyzed the data: SA ALL MDM RS JDR EBG TAM. Contributed reagents/materials/analysis tools: SA ALL MDM RS DKN MF NN JDR EBG TAM. Wrote the paper: SA ALL MDM RS JDR EBG TAM.